Joshua D Brody (Joshua Brody)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Tyrosine Kinase

Hodgkin Lymphoma

Dendritic Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Xiufen Chen, Jovian Yu, Girish Venkataraman, Sonali M Smith, Mengjie Chen, Alan Cooper, Sravya Tumuluru, Joshua D Brody, James K Godfrey, Justin Kline
T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses. Cancer immunology research 12 (3) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Xiufen Chen, Jovian Yu, Girish Venkataraman, Sonali M Smith, Mengjie Chen, Alan Cooper, Sravya Tumuluru, Joshua D Brody, James K Godfrey, Justin Kline
T cell states, repertoire and function in classical Hodgkin lymphoma revealed through single-cell analyses. Cancer immunology research (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie M Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Xiufen Chen, Jovian Yu, Girish Venkataraman, Sonali M Smith, Mengjie Chen, Alan Cooper, Sravya Tumuluru, Joshua D Brody, James K Godfrey, Justin Kline
T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses. Cancer immunology research 12 (3) (2024)
Judit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, Kristy Kim, Mark Aleynick, Linda Hammerich, Ranjan Upadhyay, Michael Yellin, Henry Marsh, Daniel Oreper, Suchit Jhunjhunwala, Christine Moussion, Miriam Merad, Brian D Brown, Adolfo García-Sastre, Joshua D Brody
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity. Nature communications 13 (1) (2022)
Theodora Anagnostou, Joshua D Brody
In CAR T cell-treated lymphomas, the T cell rich get richer. Nature medicine 28 (9) (2022)
John G Kuruvilla, Philippe Armand, Mehdi Hamadani, Justin Kline, Craig H Moskowitz, David Avigan, Joshua D Brody, Vincent Ribrag, Alex F Herrera, Judith Trotman, Abraham Kanate, Pier Luigi Zinzani, Jacob Bitran, Hervé Ghesquières, Stephen J Schuster, Mohammed Farooqui, Patricia Marinello, Nancy L Bartlett
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study. Leukemia & lymphoma (2022)
Michael L Olson, Erica R Vander Mause, Sabarinath V Radhakrishnan, Joshua D Brody, Aaron P Rapoport, Alana L Welm, Djordje Atanackovic, Tim Luetkens
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion. Leukemia 36 (7) (2022)
Matthew J Lin, Judit Svensson-Arvelund, Gabrielle S Lubitz, Aurélien Marabelle, Ignacio Melero Bermejo, Brian D Brown, Joshua D Brody
Cancer vaccines: the next immunotherapy frontier. Nature cancer 3 (8) (2022)
Oliver Van Oekelen, Adolfo Aleman, Bhaskar Upadhyaya, Sandra Schnakenberg, Deepu Madduri, Somali Gavane, Julie Teruya-Feldstein, John F Crary, Mary E Fowkes, Charles B Stacy, Seunghee Kim-Schulze, Adeeb Rahman, Alessandro Laganà, Joshua D Brody, Miriam Merad, Sundar Jagannath, Samir S Parekh
Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature medicine (2021)
Xin Xu, Matko Kalac, Michael Markson, Mark Chan, Joshua D Brody, Govind Bhagat, Rosalind L Ang, Diana Legarda, Scott J Justus, Feng Liu, Qingshan Li, Huabao Xiong, Adrian T Ting
Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL). Cell death & disease 11 (2) (2020)
Linda Hammerich, Thomas U Marron, Ranjan Upadhyay, Judit Svensson-Arvelund, Maxime Dhainaut, Shafinaz Hussein, Yougen Zhan, Dana Ostrowski, Michael Yellin, Henry C Marsh, Andres M Salazar, Adeeb H Rahman, Brian D Brown, Miriam Merad, Joshua D Brody
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nature medicine 25 (5) (2019)